Minimally Invasive Methods for Staging in Lung Cancer: Systematic Review and Meta-Analysis

DSpace/Manakin Repository

Minimally Invasive Methods for Staging in Lung Cancer: Systematic Review and Meta-Analysis

Citable link to this page

 

 
Title: Minimally Invasive Methods for Staging in Lung Cancer: Systematic Review and Meta-Analysis
Author: Labarca, Gonzalo; Aravena, Carlos; Ortega, Francisco; Arenas, Alex; Majid, Adnan; Folch, Erik; Mehta, Hiren J.; Jantz, Michael A.; Fernandez-Bussy, Sebastian

Note: Order does not necessarily reflect citation order of authors.

Citation: Labarca, Gonzalo, Carlos Aravena, Francisco Ortega, Alex Arenas, Adnan Majid, Erik Folch, Hiren J. Mehta, Michael A. Jantz, and Sebastian Fernandez-Bussy. 2016. “Minimally Invasive Methods for Staging in Lung Cancer: Systematic Review and Meta-Analysis.” Pulmonary Medicine 2016 (1): 1024709. doi:10.1155/2016/1024709. http://dx.doi.org/10.1155/2016/1024709.
Full Text & Related Files:
Abstract: Introduction:. Endobronchial ultrasound (EBUS) is a procedure that provides access to the mediastinal staging; however, EBUS cannot be used to stage all of the nodes in the mediastinum. In these cases, endoscopic ultrasound (EUS) is used for complete staging. Objective. To provide a synthesis of the evidence on the diagnostic performance of EBUS + EUS in patients undergoing mediastinal staging. Methods. Systematic review and meta-analysis to evaluate the diagnostic yield of EBUS + EUS compared with surgical staging. Two researchers performed the literature search, quality assessments, data extractions, and analyses. We produced a meta-analysis including sensitivity, specificity, and likelihood ratio analysis. Results. Twelve primary studies (1515 patients) were included; two were randomized controlled trials (RCTs) and ten were prospective trials. The pooled sensitivity for combined EBUS + EUS was 87% (CI 84–89%) and the specificity was 99% (CI 98–100%). For EBUS + EUS performed with a single bronchoscope group, the sensitivity improved to 88% (CI 83.1–91.4%) and specificity improved to 100% (CI 99-100%). Conclusion. EBUS + EUS is a highly accurate and safe procedure. The combined procedure should be considered in selected patients with lymphadenopathy noted at stations that are not traditionally accessible with conventional EBUS.
Published Version: doi:10.1155/2016/1024709
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081694/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:29626121
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters